RenovoRx Closes $6.1 Million Private Placement
With Material Participation From Insiders, Offering Proceeds to Help Drive Company Towards Second Interim Analysis of the Pivotal TIGeR-PaC Phase III Clinical Trial by Late 2024 January 29, 2024 08:30 AM Eastern Standard Time LOS…